Kidney transplant recipients receive therapeutic immunosuppression that impairs their
immune responses to the COVID-19 mRNA vaccine. For this reason, this vulnerable patient …

The effects of the coronavirus disease-2019 (COVID-19) pandemic, particularly among
those with chronic kidney disease (CKD), who commonly have defects in humoral and …

Methods| All kidney transplant recipients followed up in the outpatient Kidney
Transplantation Department of Strasbourg University Hospital between January 20, 2021 …

Kidney transplant recipients (KTRs) are extremely vulnerable to SARS‐CoV‐2 infection and
show an impaired immune response to SARS‐CoV‐2 vaccination. We analyzed factors …

Infection is the second leading cause of death in patients with chronic kidney disease (CKD).
Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize …

Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Background The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in
kidney transplant (KT) recipients. Here, we provide a thorough assessment of the …

To the editor: Several reports have highlighted the poor humoral immune response of kidney
transplant recipients following coronavirus disease 2019 (COVID-19) mRNA vaccination …

To the editor: Solid organ transplantation (SOT) recipients are at very high risk of developing
severe coronavirus disease 2019 (COVID-19). 1 Despite the implementation of a third dose …